Dimerix Limited (ASX:DXB)

Revenue by Product

Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	NaN - NaN
Biopharmaceutical Drugs	8.39M	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceutical Drugs Growth	-6.58%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	NaN - NaN
Australia	8.39M	Log In	Log In	Log In	Log In	Upgrade
Australia Growth	-6.58%	Log In	Log In	Log In	Log In	Upgrade